Real-world evidence of first-or second-line immune checkpoint inhibitors versus chemotherapy in advanced NSCLC: A prospective pragmatic multicenter Korean study
- Authors
- Kim, J.; Park, S.; Lee, G- W.; Kim, I. H.; Kim, D- W.; Lee, Y- G.; Cho, J. H.; Cho, E. K.; Lee, H. W.; Park, J. H.; Kang, E. J.; Lee, Y.; Jung, H. A.; Sun, J- M.; Lee, S- H.; Ahn, J. S.; Ahn, M- J.
- Issue Date
- Dec-2025
- Publisher
- Oxford University Press
- Citation
- Annals of Oncology, v.36
- Indexed
- SCIE
SCOPUS
- Journal Title
- Annals of Oncology
- Volume
- 36
- URI
- https://scholarworks.gnu.ac.kr/handle/sw.gnu/82211
- DOI
- 10.1016/j.annonc.2025.10.745
- ISSN
- 0923-7534
1569-8041
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medicine > Journal Articles

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.